↓ Skip to main content

Cochrane Database of Systematic Reviews

Piracetam for reducing the incidence of painful sickle cell disease crises.

Overview of attention for article published in Cochrane database of systematic reviews, April 2007
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
16 Mendeley
Title
Piracetam for reducing the incidence of painful sickle cell disease crises.
Published in
Cochrane database of systematic reviews, April 2007
DOI 10.1002/14651858.cd006111.pub2
Pubmed ID
Authors

Al Hajeri AA, Fedorowicz Z, Omran A, Tadmouri GO, Al Hajeri, Amani, Fedorowicz, Zbys, Omran, Ahmed, Tadmouri, Ghazi O

Abstract

Sickle cell disease is one of the most common genetic disorders. Sickle cell crises in which irregular and dehydrated cells contribute to blocking of blood vessels are characterised by episodes of pain. Treatment is mainly supportive and symptomatic. In vitro studies with piracetam indicate that it has the potential for inhibition and a reversal of the process of sickling of erythrocytes.

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 25%
Student > Bachelor 3 19%
Researcher 2 13%
Professor 2 13%
Librarian 1 6%
Other 3 19%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 5 31%
Agricultural and Biological Sciences 3 19%
Psychology 3 19%
Economics, Econometrics and Finance 1 6%
Social Sciences 1 6%
Other 1 6%
Unknown 2 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2017.
All research outputs
#3,237,513
of 11,841,124 outputs
Outputs from Cochrane database of systematic reviews
#6,129
of 9,070 outputs
Outputs of similar age
#30,883
of 118,424 outputs
Outputs of similar age from Cochrane database of systematic reviews
#45
of 85 outputs
Altmetric has tracked 11,841,124 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 9,070 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 118,424 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.